High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate

被引:62
作者
Tao, Rong [1 ,5 ]
Hoover, Holly E. [1 ]
Honbo, Norman [1 ]
Kalinowski, Mikaila [1 ]
Alano, Conrad C. [3 ,4 ]
Karliner, Joel S. [1 ,6 ]
Raffai, Robert [2 ]
机构
[1] Univ Calif San Francisco, Cardiol Sect, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Surg Serv, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Neurol Serv, Vet Affairs Med Ctr, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[5] Jiao Tong Univ, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China
[6] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2010年 / 298卷 / 03期
关键词
ISCHEMIA-REPERFUSION INJURY; SMOOTH-MUSCLE-CELLS; IN-VIVO; ISCHEMIA/REPERFUSION INJURY; LYSOPHOSPHOLIPID RECEPTOR; VASCULAR-PERMEABILITY; ENDOTHELIAL-CELLS; HDL; SPHINGOSINE-1-PHOSPHATE; HEARTS;
D O I
10.1152/ajpheart.00902.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tao R, Hoover HE, Honbo N, Kalinowski M, Alano CC, Karliner JS, Raffai R. High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol 298: H1022-H1028, 2010. First published January 8, 2010; doi:10.1152/ajpheart.00902.2009.-The lipid mediator sphingosine 1-phosphate (S1P) confers survival benefits in cardiomyocytes and isolated hearts subjected to oxidative stress. High-density lipoprotein (HDL) is a major carrier of S1P in the serum, but whether HDL-associated S1P directly mediates survival in a preparation composed exclusively of cardiomyocytes has not been demonstrated. Accordingly, we tested the hypothesis that signal activation and survival during simulated ischemia-reperfusion injury in response to HDL require lipoprotein-associated S1P. As a model, we used adult mouse cardiomyocytes subjected to hypoxia-reoxygenation. Cells were treated or not with autologous mouse HDL, which significantly increased myocyte viability as measured by trypan blue exclusion. This survival effect was abrogated by the S1P(1) and SIP3 receptor antagonist VPC 23019. The selective S1P(3) antagonist CAY10444, the G(i) antagonist pertussis toxin, the MEK (MAPK/ERK) kinase inhibitor PD-98059, and the phosphoinositide-3 kinase inhibitor wortmannin also inhibited the prosurvival effect of HDL. We observed that HDL activated both Akt (protein kinase B) and the MEK1/2-ERK1/2 pathway and also stimulated phosphorylation of glycogen synthase kinase-3 beta. ERK1/2 activation was through an S1P(1) subtype receptor-G(i) protein-dependent pathway, whereas the activation of Akt was inhibited by CAY10444, indicating mediation by S1P(3) subtype receptors. We conclude that HDL, via its cargo of S1P, can directly protect cardiomyocytes against simulated oxidative injury in the absence of vascular effects and that prosurvival signal activation is dependent on both S1P(1) and S1P(3) subtype receptors.
引用
收藏
页码:H1022 / H1028
页数:7
相关论文
共 46 条
[1]   HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects [J].
Argraves, Kelley M. ;
Argraves, W. Scott .
JOURNAL OF LIPID RESEARCH, 2007, 48 (11) :2325-2333
[2]   HDL cholesterol and protective factors in atherosclerosis [J].
Assmann, G ;
Gotto, AM .
CIRCULATION, 2004, 109 (23) :8-14
[3]   Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection [J].
Bellosta, Stefano ;
Gomaraschi, Monica ;
Canavesi, Monica ;
Rossoni, Giuseppe ;
Monetti, Mara ;
Franceschini, Guido ;
Calabresi, Laura .
FEBS LETTERS, 2006, 580 (25) :5974-5978
[4]   Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology [J].
Brinkmann, Volker .
PHARMACOLOGY & THERAPEUTICS, 2007, 115 (01) :84-105
[5]   High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-α content and enhancing prostaglandin release [J].
Calabresi, L ;
Rossoni, G ;
Gomaraschi, M ;
Sisto, F ;
Berti, F ;
Franceschini, G .
CIRCULATION RESEARCH, 2003, 92 (03) :330-337
[6]   Acute effects of high-density lipoproteins: biochemical basis and clinical findings [J].
Chiesa, Giulia ;
Parolini, Cinzia ;
Sirtori, Cesare R. .
CURRENT OPINION IN CARDIOLOGY, 2008, 23 (04) :379-385
[7]   Sphingosine 1-phosphate analogs as receptor antagonists [J].
Davis, MD ;
Clemens, JJ ;
Macdonald, TL ;
Lynch, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (11) :9833-9841
[8]  
Di Napoli P, 1997, Cardiologia, V42, P59
[9]   Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides [J].
Gomaraschi, Monica ;
Calabresi, Laura ;
Rossoni, Giuseppe ;
Iametti, Stefania ;
Franceschini, Guido ;
Stonik, John A. ;
Remaley, Alan T. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (02) :776-783
[10]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353